1. Home
  2. AVDL vs SONO Comparison

AVDL vs SONO Comparison

Compare AVDL & SONO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avadel Pharmaceuticals plc

AVDL

Avadel Pharmaceuticals plc

HOLD

Current Price

$21.51

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo Sonos Inc.

SONO

Sonos Inc.

HOLD

Current Price

$15.87

Market Cap

2.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVDL
SONO
Founded
2015
2002
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Consumer Electronics/Video Chains
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.2B
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
AVDL
SONO
Price
$21.51
$15.87
Analyst Decision
Buy
Strong Buy
Analyst Count
9
3
Target Price
$18.38
$19.67
AVG Volume (30 Days)
1.6M
1.3M
Earning Date
03-02-2026
02-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$248,517,000.00
$1,443,276,000.00
Revenue This Year
$65.47
$4.35
Revenue Next Year
$30.88
$7.90
P/E Ratio
N/A
N/A
Revenue Growth
79.88
N/A
52 Week Low
$6.38
$7.63
52 Week High
$23.57
$19.82

Technical Indicators

Market Signals
Indicator
AVDL
SONO
Relative Strength Index (RSI) 56.85 31.36
Support Level $21.45 $16.49
Resistance Level $21.60 $17.32
Average True Range (ATR) 0.08 0.64
MACD -0.05 -0.18
Stochastic Oscillator 48.78 2.28

Price Performance

Historical Comparison
AVDL
SONO

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About SONO Sonos Inc.

Sonos Inc is an audio company dedicated to elevating life through sound, offering a connected platform that brings together music, movies, stories, and conversations. Its portfolio includes home theater speakers, components, plug-in and portable speakers and headphones, known for exceptional sound, thoughtful design, ease of use and seamless access to audio content. Its partner products and other revenue categories include accessories for home integration, such as custom-designed stands, mounts, and shelving units, along with partnerships for architectural speakers and automotive sound systems, as well as licensing, advertising revenue, and subscription-based services. The company operates in the United States and other countries, with the majority of revenue coming from the United States.

Share on Social Networks: